Mitochondrial biogenesis-related proteins

Mitochondrial biogenesis-related proteins" is not a single molecular target but a broad group encompassing numerous proteins that regulate, mediate, or execute the process of mitochondrial biogenesis, which involves the synthesis, import, assembly, and quality control of mitochondrial proteins. These proteins include transcriptional regulators (such as PGC-1α, NRF1, and TFAM), import machinery components (TOM/TIM/SAM complexes), mitochondrial chaperones (such as Hsp70 and Hsp60)[8], solute carriers (like the SLC25 family)[2], and recently characterized mitochondrial-derived peptides (MDPs) (e.g., humanin, MOTS-c, SHLPs)[5]. Collectively, these proteins orchestrate the increase in mitochondrial mass and function in response to physiological demands or stress, impact cellular energy metabolism, and modulate signals relevant in diseases such as cancer, metabolic, cardiovascular, and neurodegenerative disorders[4][5]. Because "mitochondrial biogenesis-related proteins" refers to a diverse and complex network rather than a defined molecular entity, it is not considered an individual therapeutic target but rather a functional category or process encompassing many potential and established druggable proteins and pathways.

Other names

Mitochondrial biogenesis proteinsMitochondrial biogenesis factorsMitochondrial biogenesis regulators

- Activation of AMPK/PGC-1α signaling pathway - Promotion of transcription factors (CREB-mediated) - Activation of HAT1 and DNMT1 epigenetic modulators - Peptide modulation of mitochondrial mass (MDPs)